Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

  • Komisja Europejska
  • CORDIS
  • Serwis Projekty i wyniki
  • Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

From 2015-05-01 to 2015-10-31, closed project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

Italy

Call for proposal:

H2020-SMEINST-1-2014See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Related information

Open Access

Coordinator

NATIMAB THERAPEUTICS SRL
Italy

EU contribution: EUR 50 000


VIA RIBES 5
10010 COLLERETTO GIACOSA TORINO
Italy
Record Number: 196535 / Last updated on: 2015-11-25